S. W. SAPPINGTON, M.D., F.A.C.P.; GRANT O. FAVORITE, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
The therapy of infections has developed almost exclusively along the lines of specificity, and an excellent example of this is the use of the many types of anti-serum for the treatment of pneumococcus pneumonia. Likewise in drug therapy, the real successes have been mostly specific in their application. Used at first as a specific in beta hemolytic streptococcus infections, the therapeutic trial of sulfanilamide and its derivatives has been extended clinically and experimentally to cover the most remarkable variety of infections. This list includes such dissimilar organisms as gram positive and negative micrococci, aerobic and anaerobic bacilli, acid fast bacilli,
SAPPINGTON SW, FAVORITE GO. SULFANILAMIDE AND MENINGITIS*. Ann Intern Med. 1939;13:576–597. doi: https://doi.org/10.7326/0003-4819-13-4-576
Download citation file:
Published: Ann Intern Med. 1939;13(4):576-597.
CNS Infections, Infectious Disease, Neurology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use